Phenomenology, Structure, and Dynamic of Psychedelic States
- PMID: 28025814
- DOI: 10.1007/7854_2016_459
Phenomenology, Structure, and Dynamic of Psychedelic States
Erratum in
-
Erratum to: Phenomenology, Structure, and Dynamic of Psychedelic States.Curr Top Behav Neurosci. 2018;36:1. doi: 10.1007/7854_2017_477. Curr Top Behav Neurosci. 2018. PMID: 28710675 No abstract available.
Abstract
Classic serotonergic hallucinogens or psychedelics produce an altered states of consciousness (ASC) that is characterized by profound alterations in sensory perception, mood, thought including the perception of reality, and the sense of self. Over the past years, there has been considerable progress in the search for invariant and common features of psychedelic states. In the first part of this review, we outline contemporary approaches to characterize the structure of ASCs by means of three primary etiology-independent dimensions including oceanic boundlessness, anxious ego-dissolution, and visionary restructuralization as well as by 11 lower-order factors, all of which can be reliably measured by the altered state of consciousness questionnaire (APZ-OAV). The second part sheds light on the dynamic nature of psychedelic experiences. Frequently, psychedelic subjects progress through different stages over time and levels of changes along a perception-hallucination continuum of increasing arousal and ego-dissolution. We then review in detail the acute effects of psychedelics on sensory perception, emotion, cognition, creativity, and time perception along with possible neural mechanisms underlying them. The next part of this review outlines the influence of non-pharmacological factors (predictors) on the acute psychedelic experience, such as demographics, genetics, personality, mood, and setting, and also discusses some long-term effects succeeding the acute experience. The last part presents some recent concepts and models attempting to understand different facets of psychedelic states of consciousness from a neuroscientific perspective.
Keywords: Altered states of consciousness; Hallucinogens; Human; Lysergic acid diethylamide (LSD); Psilocybin; Psychedelics; Serotonin.
Similar articles
-
Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.Curr Neuropharmacol. 2017;15(7):1032-1042. doi: 10.2174/1573413713666170619092629. Curr Neuropharmacol. 2017. PMID: 28625125 Free PMC article. Review.
-
The standardized psychometric assessment of altered states of consciousness (ASCs) in humans.Pharmacopsychiatry. 1998 Jul;31 Suppl 2:80-4. doi: 10.1055/s-2007-979351. Pharmacopsychiatry. 1998. PMID: 9754838 Review.
-
Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics.J Psychopharmacol. 2024 Jan;38(1):19-32. doi: 10.1177/02698811231200019. Epub 2023 Nov 16. J Psychopharmacol. 2024. PMID: 37969069 Free PMC article. Review.
-
Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution.Curr Biol. 2016 Apr 25;26(8):1043-50. doi: 10.1016/j.cub.2016.02.010. Epub 2016 Apr 13. Curr Biol. 2016. PMID: 27085214 Clinical Trial.
-
Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains.Neuroimage. 2020 Oct 15;220:117049. doi: 10.1016/j.neuroimage.2020.117049. Epub 2020 Jun 30. Neuroimage. 2020. PMID: 32619708
Cited by
-
P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap.Hum Brain Mapp. 2020 Dec;41(17):4982-4996. doi: 10.1002/hbm.25174. Epub 2020 Aug 21. Hum Brain Mapp. 2020. PMID: 32820851 Free PMC article. Clinical Trial.
-
Converging theories on dreaming: Between Freud, predictive processing, and psychedelic research.Front Hum Neurosci. 2023 Feb 16;17:1080177. doi: 10.3389/fnhum.2023.1080177. eCollection 2023. Front Hum Neurosci. 2023. PMID: 36875230 Free PMC article. Review.
-
The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial.Psychopharmacology (Berl). 2019 Apr;236(4):1159-1170. doi: 10.1007/s00213-018-5119-x. Epub 2018 Nov 26. Psychopharmacology (Berl). 2019. PMID: 30478716 Free PMC article. Clinical Trial.
-
Transformative experience and informed consent to psychedelic-assisted psychotherapy.Front Psychol. 2023 May 26;14:1108333. doi: 10.3389/fpsyg.2023.1108333. eCollection 2023. Front Psychol. 2023. PMID: 37303902 Free PMC article.
-
Addressing blinding in classic psychedelic studies with innovative active placebos.Int J Neuropsychopharmacol. 2025 Apr 11;28(4):pyaf023. doi: 10.1093/ijnp/pyaf023. Int J Neuropsychopharmacol. 2025. PMID: 40183712 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous